Quantity and subtypes of dendritic cells in patients with immune related pancytopenia and their clinical significance.
- Author:
Guang-Shuai TENG
1
;
Rong FU
;
Hui LIU
;
Hong-Lei WANG
;
Yi-Hao WANG
;
Er-Bao RUAN
;
Wen QÜ
;
Yong LIANG
;
Guo-Jin WANG
;
Xiao-Ming WANG
;
Hong LIU
;
Yu-Hong WU
;
Jia SONG
;
Hua-Quan WANG
;
Li-Min XING
;
Jing GUAN
;
Jun WANG
;
Li-Juan LI
;
Zong-Hong SHAO
Author Information
1. Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Blood Cell Count;
Case-Control Studies;
Child;
Child, Preschool;
Dendritic Cells;
cytology;
immunology;
Female;
Flow Cytometry;
Humans;
Male;
Middle Aged;
Pancytopenia;
blood;
immunology;
Young Adult
- From:
Journal of Experimental Hematology
2012;20(3):722-726
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to investigate the quantity and subtypes of dendritic cells (DC) in patients with immune related pancytopenia (IRP) and to explore the role of DC in pathogenesis of IRP. The quantity of plasmacytoid dendritic cells (pDC, Lin(-)HLA-DR(+) CD123(+) cells) and myeloid dendritic cells (mDC, Lin(-)HLA-DR(+) CD11c(+)cells) in peripheral blood of 65 patients with IRP (37 new diagnosed and 28 remitted) and 17 healthy controls were analyzed by flow cytometry. The results indicated that the ratio of pDC in peripheral blood mononuclear cells (PBMNC) was (0.91 ± 064)% in new diagnosed group, which was significantly higher than that in remission group (0.39 ± 0.11)% and control group (0.29 ± 0.13)% (P < 0.01), while this ratio of pDC in remission group was higher than that in control group (P < 0.05). The ratio of mDC in PBMNC was (0.21 ± 0.20)% in new diagnosed group and (0.34 ± 0.21)% in remission group respectively, there was no statistical difference as compared with control group (0.29 ± 0.09)% (P > 0.05). The ratio of pDC to mDC in new diagnosed group was 6.75 ± 7.11, which was significantly higher than that in remission group (1.55 ± 0.93) and control group (1.07 ± 0.43, P < 0.01), there was no statistical difference between the ratio of remission group and control group (P > 0.05). The ratio of pDC in PBMNC of IRP group negatively correlated to ratio of Th1/Th2 (r = -0.347, P < 0.05), and positively correlated to the ratio of auto-antibody on membrane of BMMNC (r = 0.606, P < 0.05) and to the quantity of CD5(+)B cells (r = 0.709, P < 0.05), while it negatively correlated to the levels of hemoglobin (r = -0.381, P < 0.01) and platelets (r = -0.343, P < 0.01). The ratio of mDC in PBMNC positively correlated to the ratio of Th1/Th2 (r = 0.595, P < 0.05) and the level of hemoglobin (r = 0.292, P < 0.05). The ratio of pDC/mDC negatively correlated to ratio of Th1/Th2 (r = -0.395, P < 0.05), it positively correlated to the level of antibody on membrane of BMMNC (r = 0.421, P < 0.05) and the quantity of CD5(+)B cells (r = 0.423, P < 0.05), while it negatively correlated to the levels of hemoglobin (r = -0.304, P < 0.05) and platelets (r = -0.287, P < 0.05). It is concluded that the quantity of pDC in peripheral blood of IRP patients increases, which may be related to the immunopathogenesis of IRP.
